Brief: Longeveron® Lomecel-B™ Data In Alzheimer’S Disease Selected For Late Breaking Poster Presentation At The Clinical Trials On Alzheimer’S Disease Conference
14/10/2024 14:07
Oct 14 (Reuters) - Longeveron Inc LGVN.O :
* LONGEVERON® LOMECEL-B™ DATA IN ALZHEIMER’S DISEASE
SELECTED FOR
LATE BREAKING POSTER PRESENTATION AT THE CLINICAL TRIALS ON
ALZHEIMER’S DISEASE CONFERENCE (CTAD24)
Source text for Eikon: ID:nGNX9kqmfV
Further company coverage: LGVN.O
((Reuters.Briefs@thomsonreuters.com;))